Europe Interventional Imaging Market to Grow with a CAGR of CAGR of 6.58% through 2030
Advancements in imaging technologies and rising
prevalence of chronic diseases is expected to drive the Europe Interventional
Imaging Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Europe Interventional
Imaging Market - By Country, Competition, Forecast and Opportunities, 2030F”,
the Europe Interventional Imaging Market stood at USD 2.77 Billion in 2024 and is expected
to reach USD 4.07 Billion by 2030 with a CAGR of 6.58% during the forecast
period.
The Europe interventional imaging market
is experiencing significant growth driven by advancements in medical imaging
technologies, the increasing demand for minimally invasive procedures, and the
rising prevalence of chronic diseases such as cardiovascular conditions,
cancer, and neurological disorders. Interventional imaging systems, including
fluoroscopy, computed tomography (CT), magnetic resonance imaging (MRI), and
ultrasound, have become essential tools in guiding a wide range of minimally
invasive procedures across multiple medical specialties. These technologies
enable real-time, high-resolution imaging, allowing physicians to visualize and
navigate inside the human body with exceptional accuracy, reducing the need for
traditional, more invasive surgical interventions.
One of the key factors driving the
growth of the European interventional imaging market is the shift towards
minimally invasive procedures. These procedures, which involve small incisions
and the use of imaging guidance to perform interventions, offer significant
benefits over traditional surgery, including reduced recovery times, lower risk
of complications, less postoperative pain, and shorter hospital stays. As a
result, there has been a growing preference for procedures such as
catheter-based therapies, biopsies, stent placements, and tumor ablations, all
of which rely heavily on interventional imaging systems for precision. The
increasing adoption of these procedures across various medical fields,
including cardiology, oncology, neurology, and musculoskeletal medicine, has
directly contributed to the demand for advanced imaging technologies.
The growing aging population in Europe
is another key factor driving the market. As the elderly population is more
susceptible to chronic conditions such as heart disease, stroke, cancer, and
orthopedic disorders, the need for effective diagnostic and therapeutic
interventions has increased. The ability of interventional imaging systems to
provide detailed, real-time visuals during these procedures has proven critical
in improving patient outcomes, thereby encouraging greater adoption. The rise
in lifestyle-related diseases, such as obesity and diabetes, further
exacerbates the demand for advanced interventional imaging, as these conditions
often lead to complications requiring surgical interventions.
Technological innovations have played a
significant role in advancing interventional imaging systems. The integration
of artificial intelligence (AI) and machine learning algorithms into imaging
software has enhanced the accuracy and efficiency of image interpretation.
AI-based systems can now assist clinicians in detecting abnormalities, planning
procedures, and predicting patient outcomes more effectively. Hybrid imaging
systems, such as PET/CT and SPECT/CT, have also gained popularity, as they
combine the advantages of both functional and anatomical imaging, enabling more
comprehensive diagnosis and treatment planning. The development of 3D imaging
technologies and advanced software for real-time image processing further
enhances the precision of interventional procedures, making them safer and more
effective.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on " Europe Interventional Imaging Market”
The Europe Interventional Imaging Market is segmented
into offering, application, end user, country distribution, and company.
Based on end user, Hospitals are currently dominating
the Europe interventional imaging market. The primary reason for this dominance
lies in the complexity and volume of procedures performed in hospital settings.
Hospitals, particularly large academic medical centers and specialized
healthcare institutions, have the necessary infrastructure, advanced imaging
technologies, and specialized medical staff to support complex interventional
imaging procedures. These procedures, which include a wide range of minimally
invasive treatments such as catheter-based interventions, biopsies, stent
placements, and tumor ablations, require high-end imaging systems like CT, MRI,
fluoroscopy, and ultrasound to ensure precision and safety.
Hospitals have the resources to invest in
state-of-the-art interventional imaging equipment, offering them a competitive
edge in providing high-quality care for a variety of conditions, including
cardiovascular diseases, cancer, neurological disorders, and musculoskeletal
problems. These facilities are equipped with the necessary infrastructure, such
as dedicated interventional radiology suites, advanced imaging technology, and
integrated surgical capabilities, allowing for a comprehensive approach to patient
care. As the demand for minimally invasive procedures continues to rise due to
their benefits, such as shorter recovery times and reduced complications,
hospitals remain the primary setting for these procedures. Hospitals benefit
from established reimbursement frameworks and funding sources, which enable
them to invest in and maintain cutting-edge imaging systems. Many European
countries also have well-developed national healthcare systems that prioritize
hospitals for the allocation of resources, including advanced medical devices
and imaging technologies, ensuring that hospitals remain at the forefront of
medical innovation.
Based on country, the United Kingdom is the second
dominant country in the Europe interventional imaging market. After Germany,
the UK stands out due to its highly advanced healthcare system, strong
healthcare infrastructure, and significant adoption of medical imaging technologies.
The UK's National Health Service (NHS), which serves a large portion of the
population, plays a pivotal role in providing access to advanced medical care,
including interventional imaging systems, across both public and private healthcare
facilities. The NHS is committed to improving patient outcomes by adopting
minimally invasive procedures, which rely heavily on real-time imaging
technologies such as fluoroscopy, CT, and MRI.
The high incidence of chronic diseases, such as
cardiovascular conditions, cancer, and neurological disorders, in the UK has
led to an increased demand for advanced imaging systems. These diseases require
precise imaging to guide interventions such as catheter-based therapies, stent
placements, biopsies, and tumor ablations, making interventional imaging an
essential part of the treatment process. The UK's aging population continues to
drive the demand for interventional imaging, as older adults are more likely to
require complex, minimally invasive procedures for various health issues. The
UK is also a leader in healthcare innovation, with many hospitals and medical
centers continually upgrading their facilities with the latest interventional
imaging technologies to provide optimal care. The government's investment in
healthcare and medical research has fostered the growth of advanced imaging
technologies, including hybrid imaging systems, artificial intelligence
(AI)-driven image analysis, and 3D imaging, all of which are gaining traction
in the country's healthcare institutions.
Major companies operating in Europe Interventional
Imaging Market are:
- Koninklijke Philips NV
- Medtronic GmbH
- Siemens Healthineers AG
- Canon Medical Systems Europe B.V.
- Angiopro GmbH
- B. Braun Melsungen AG
- GE Healthcare Finland Oy
- Carestream Health Netherlands, B.V.
- FUJIFILM Europe GmbH
- Shimadzu Europa GmbH
- ESAOTE Europe B.V.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The future of the Europe interventional imaging
market looks promising, driven by advancements in imaging technologies, the
growing preference for minimally invasive procedures, and the increasing
prevalence of chronic diseases. As healthcare systems across Europe continue to
prioritize patient-centric care, the demand for high-precision imaging
solutions that enable safe, effective, and minimally invasive interventions
will rise. Innovations such as AI-powered imaging systems, hybrid imaging
technologies, and real-time 3D visualization will further enhance procedural
accuracy. The aging population and the increasing burden of lifestyle-related
diseases will fuel the need for interventional imaging. As healthcare
infrastructure modernizes and investments in medical technology expand, the
market is set to experience continued growth, positioning interventional
imaging as a critical component of future healthcare delivery”, said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Europe Interventional Imaging Market By Offering (Interventional Imaging Systems, Interventional Imaging Software, and Consumables), By Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynecology, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Clinics), By Country, Competition, Forecast and Opportunities, 2020-2030F”, has evaluated the future growth potential of Europe
Interventional Imaging Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Europe Interventional
Imaging Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com